Schizophrenia is a serious mental illness that requires continuous and effective long-term
management to reduce symptoms, improve quality of life, and prevent relapse. Oral …

Objective Neuroleptic malignant syndrome (NMS) is a potentially fatal, idiosyncratic reaction
to antipsychotics. Due to low incidence of NMS, research on risk factors of mortality …

Introduction Long-acting injectable antipsychotics (LAIs) are associated with multiple
positive outcomes in psychosis, but it is unclear whether LAIs are associated with worse …

Introduction Maintenance antipsychotic treatment improves multiple outcomes in people with
schizophrenia. These benefits are challenged by medication nonadherence, which is a …

Objectives: Co-occurring substance use disorders (SUDs) among individuals with
schizophrenia are a prevalent and complex psychiatric comorbidity, which is associated with …

Background: The drug reaction with eosinophilia and systemic symptoms (DRESS)
syndrome is a drug-induced hypersensitivity reaction. Aims: Aim was to review reports of …

Objective: Switching of antipsychotic medications, which are used for many psychiatric
conditions, is common. However, reasons and clinical documentation of such switches have …

Abstract Background and Hypothesis Long-acting injectable antipsychotic drugs (LAIs) are
mainly used for relapse prevention but could also be advantageous for acutely ill patients …

Approximately 8% of patients with schizophrenia are diagnosed before age 18, and 18%
experience their first symptoms before age 18. This narrative review explores the …

Background Schizophrenia is mostly a chronic disorder whose symptoms include psychosis,
negative symptoms and cognitive dysfunction. Poor adherence is common and related …